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Endometriosis is a reproductive disease characterized by the growth of endometrial cells at sites outside the uterus. This disease is a serious
disorder associated with chronic pain and infertility, which may be present in 6 million women in this country. Traditional medical therapy has
consisted of hormonal regimens that limit the action of endogenous estrogen. The etiology of endometriosis is unknown, but studies suggest that
soluble factors known as cytokines play a role in disease pathogenesis. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD or dioxin) is an environmental
toxicant that alters the action of estrogen in reproductive organs and adversely affects immunocompetence. The incidence of endometriosis was
determined in rhesus monkeys that were chronically exposed to dioxin for a period of approximately 4 years. Ten years after termination of dioxin
treatment, the presence and severity of endometriosis was assessed by surgical laparoscopy. The incidence of endometriosis correlated with dioxin
exposure and disease severity was dependent upon the dose administered. Moderate to severe endometriosis was not found in control animals but
was documented in three of seven animals exposed to 5 ppt dioxin (43%) and in five of seven animals exposed to 25 ppt dioxin (71%). The
frequency of spontaneous disease in the control group was 33%, similar to an overall prevalence of 30% in 304 rhesus monkeys with no history of
dioxin exposure. This study indicates that endometriosis may be associated with dioxin exposure in the rhesus. In view of overwhelming evidence
that cytokines participate in the mediation of reproductive-endocrine phenomena and regulation of endometrial growth, future assessment of the
effects of environmental toxicants on reproductive health may depend upon our understanding of the bidirectional cytokine network between the
immune and endocrine systems. - Environ Health Perspect 103(Suppl 7):151-156 (1995)
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Introduction
Endometriosis-The Reproductive
Disease
Endometriosis is often described as one of
the most enigmatic disorders affecting the
reproductive health ofwomen. This disease
is defined as the growth of endometrial
cells at sites outside the uterus and is char-
acterized by infertility, chronic pain, and
adhesion formation. Studies estimate that
the prevalence of endometriosis is 10%
among reproductive-age women (1), indi-
cating that this disease may be present in
6 million women in this country (2). The
etiology ofendometriosis is unknown, and
specific factors that contribute to disease
progression have not been clearly identi-
fied. It is generally accepted that ectopic
cells either implant and proliferate follow-
ing retrograde menstruation or differenti-
ate from a primitive progenitor cell
population within the abdominal cavity
(3,4). It has been demonstrated, however,
that retrograde menstrual flow occurs in
most reproductive-age women (5), yet only
a percentage will develop this disease.
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Based upon the belief that steroids are
the major regulators of the growth and
function of ectopic endometriotic tissue,
the cornerstone of medical therapy for
endometriosis has consisted of modulating
the endogenous hormonal environment
(6). Ectopic endometrial cells can respond
to ovarian steroids and undergo cyclic
menstrual changes with periodic bleeding.
Hormonal regimens available for the treat-
ment of endometriosis include gonado-
tropin-releasing hormone agonists, the
androgen agonist danazol, progestins, and
surgical treatments such as oophorectomy.
These treatments create an acyclic, low-
estrogen endocrine environment, which
prevents bleeding, causes atrophy of
ectopic implants, and possibly minimizes
retrograde reseeding. However, the role of
steroids in the growth ofendometriotic tis-
sue is unclear. Normal uterine endome-
trium undergoes predictable histological
and biochemical changes in response to
hormones throughout the cycle. Studies
indicate that the hormonal responsive-
ness of endometrial implants may be al-
tered. Reports have shown that ectopic
Environmental Health Perspectives 151RIERETAL.
endometrial tissue is histologically asyn-
chronous with corresponding endometrium
and may display decreased or variable
estrogen and progesterone receptors (7,8).
Thus, the growth of endometrial implants
may be differentially regulated compared
to the uterine endometrium.
Immune-Endocrine Regulaion of
UterineEndometrial cli G th
Human endometrium is a complex tissue
composed of glandular structures and
endometrial stroma intimately associated
with aggregates oflymphoid cells (9). It is
thought that the biochemical and morpho-
logical changes that occur in endometrium
during the menstrual cycle are primarily
regulated by estrogen and progesterone.
However, it is unclear whether the effect of
steroid hormones is mediated directly on
target cells or exerted indirectly through
the elaboration of soluble factors within
the endometrium. A series ofrecent studies
indicate that cytokines including inter-
leukin-l (IL-1), tumor necrosis factor
(TNF), and IL-6 are produced by immune
and endocrine cell populations within the
uterine environment and participate in the
growth ofendometrium (10-13). In addi-
tion, these factors may be under the con-
trolling influence of steroid hormones
(12-17). Thus, interactions between endo-
metrial stromal, epithelial, and lymphoid
cells within the uterine environment may
be mediated by cytokines in collaboration
with steroids.
Immune-Endocrine Interacdons
viaCytokines
Data also suggest that cytokines including
IL-1, TNF, and IL-6 may alter endome-
trial functions as a result of their direct
actions on the hypothalamus, pituitary, or
gonads (10). Furthermore, cytokines may
be important mediators of reproductive-
endocrine phenomena via steroid regula-
tion ofcytokine secretion in target tissues.
Receptors for 170-estradiol have been
demonstrated in peripheral blood leuko-
cytes (18), thymic lymphocytes (18,19),
and lymphoid cells present in human
endometrium (20). Studies indicate that
either in vitro or in vivo exposure to this
steroid or pituitary peptides affects
cytokine secretion and gene expression by
leukocytes and endometrial cells (12-17).
For example, peripheral blood leukocytes
spontaneously release significantly increased
levels ofIL-1 and IL-6 after oophorectomy
as compared to women who had under-
gone hysterectomy without removal of
ovaries (16). Moreover, ovarian ablation
was accompanied by alterations in serum
levels of plasma proteins associated with
bone loss.
ImmuneAlterations inEndometriosis
Growth factors and inflammatory media-
tors produced by activated peritoneal
leukocytes have been postulated to play a
role in the pathogenesis of endometriosis
by facilitating the growth of endometrial
cells at ectopic sites (21). Peritoneal leuko-
cytes are present in increased numbers and
exist in a state ofheightened activation in
patients with this disease relative to normal
control women (21-24). Peritoneal
macrophages from patients with mild
endometriosis spontaneously produce IL-1
(25), and increased levels of TNF (26)
and IL-6 (27). Elevated levels ofinflamma-
tory cell products such as prostaglandins,
proteolytic enzymes, complement compo-
nents, IL-1, and TNF have been observed
in the peritoneal fluid ofpatients with mild
endometriosis (28). Other work also
suggests a pivotal role for peritoneal
macrophages in the establishment and
maintenance of endometriosis. Isolated
populations ofmacrophages secrete a num-
ber of cytokines capable of positively
influencing endometrial cell growth, and
peritoneal fluid obtained from women with
endometriosis increases endometrial stro-
mal cell proliferation (29-31). In view of
overwhelming evidence for the contribu-
tion of cytokines in the regulation of
endometrial function, we have postulated
that endometriosis is characterized by a
dysregulation of leukocyte cytokine pro-
duction that affects disease progression by
influencing the growth of endometrial
cells. In this regard, we have shown that
peritoneal leukocytes and endometrial cells
from patients with endometriosis exhibit
altered IL-6 responses that may result in
unregulated ectopic endometrial cell
growth (27,32,33).
EffectsofDioxin ontheReproductive
andImmuneSystems
2,3,7,8-Tetrachlorodibenzo-p-dioxin
(TCDD or dioxin) is a potent chemical
toxicant that serves as the reference com-
pound for a large class ofhalogenated aro-
matic hydrocarbons (34). Extensive
evidence using animal model systems
demonstrates that both the reproductive
and immune systems are targets for dioxin
toxicity; however, the effects of this toxin
in humans are not clear (35-40). Many of
the biochemical and toxic effects ofdioxin
appear to be mediated via binding to an
intracellular protein known as the aryl
hydrocarbon receptor. Receptor activation
follows stereospecific ligand binding, and
interaction ofthe receptor-ligand complex
with the DNA-responsive element results
in transcriptional activation (41). Target
genes for the action of dioxin include
cytochrome P450 and growth regulatory
genes involved in both inflammation and
differentiation, including plasminogen
activator inhibitor-2 and IL-l1 (41,42).
Dioxin also modulates various hormone
receptor systems that play a role in uterine
function, including estrogen receptor,
progesterone receptor, epidermal growth
factor receptor, and prolactin receptor
(43,44). Moreover, this toxicant alters the
action of estrogen in reproductive organs
in a manner that is both age dependent
and target-organ specific (44,45). Import-
antly, dioxin also adversely affects leuko-
cyte production of cytokines known to
participate in the regulation of uterine
physiology (10,46-48).
Our group had the unique opportunity
to study the effect of chronic exposure to
dioxin on the frequency and severity of
endometriosis in the rhesus monkey. This
study ras originally undertaken 17 years
ago to investigate the long-term reproduc-
tive effects of exposure to dioxin in the
rhesus. Between 1989 and 1992, three
dioxin-treated animals died of severe
infiltrating endometriosis. These animals
and others in the colony displayed symp-
toms similar to human disease at the onset
of menses, including behavior consistent
with pain. In view ofthese findings, a study
was initiated to document endometriosis in
this colony of monkeys and to determine
whether the severity of disease was corre-
lated with exposure to dioxin (49). The
prevalence ofspontaneous endometriosis in
the general population of female rhesus
monkeys located at the Harlow Primate
Laboratorywas also determined.
Methods
Detailed methods for this study have been
previously described (49). All experimental
protocols using rhesus monkeys were per-
formed in accordance with the regulations
in the "Guide for Care and Use ofLabora-
tory Animals" and the Animal Welfare Act
as amended (7 USC 2131 et Sec.) and were
approved by theAnimal Review Committee
ofthe UniversityofWisconsin, Madison.
StudyPopulation
Twenty-four feral female rhesus monkeys
(Macaca mulatta), 6 to 10 years of age,
were obtained in 1977 (Hazelton Research
Animals, Reston, VA). The animals were
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maintained under climate conditions that
simulated their natural breeding season.
Monkeys were randomly assigned to three
groups ofeight animals each. Control ani-
mals were not exposed to dioxin, animals
in the low-dose group were exposed to 5
parts per trillion (ppt) dioxin, and mon-
keys in the high-dose group were exposed
to 25 ppt dioxin; dioxin was administered
in the feed for a period ofapproximately 4
years, from late 1977 to early 1982. Bio-
accumulation ofdioxin in selected animals
was quantitated from fat biopsy specimens
obtained at several time points during and
after exposure (37).
Animals evaluated for the presence of
endometriosis consisted ofthe 17 live mon-
keys remaining in this colony in 1992 and
the three monkeys that died of extensive
endometriosis, from which the disease was
documented and staged from autopsy
notes. Animals that died before June
1992 of causes other than endometriosis
(n=4) were not considered. Although
endometriosis was not noted at autopsy, the
possibility exists that disease was present
but was not grossly apparent. Therefore,
these animals were excluded from the pre-
sent analysis to allow conservative interpre-
tation of these findings. (Inclusion of these
animals moderately strengthens the statisti-
cal significance ofthe data in this report.)
Autopsy records from female rhesus
monkeys housed at the Harlow Primate
Laboratory were reviewed to determine the
prevalence of endometriosis in the rhesus
general population. This analysis included
304 normal noncastrated females .4 years
ofage with no history ofdioxin exposure.
MixingandQuantitation of
Dioxin Diets
2,3,7,8-Tetrachlorodibenzo-p-dioxin (Dow
Chemical, Midland, MI) was prepared as a
stock solution by diluting 19.8 psg dioxin
in 1.0 ml benzene. One part stock solution
was then diluted with 3550 parts acetone;
200 ml ofthe resulting solution was mixed
with 8 kg ofmonkey chow (Ralston-Purina
Co., St. Louis, MO). Additional normal
meal was then added to yield 22.7 kg
(50 lb) of chow with a final concentration
of 50 ppt dioxin. This premix (5- and
25-lb portions) was added to normal meal
(final weight 50 lb) to make the 5-ppt and
25 ppt-diets, respectively. Diets were pel-
leted by the addition of 2 liters of water
and 1 liter of glycerine (which served as
binders) per 50-lb bag. Dioxin-free chow
was prepared for control monkeys as
described above, using benzene, acetone,
and glycerine. Dioxin was administered by
addition to the daily allotment of200 g of
monkey chow; food records documented
that the animals consumed an average of
95% oftheir daily diet. Dioxin content in
the feed was verified by gas chromato-
graph/mass spectrophotometer analysis of
selected samples over the 4-year treatment
period, as described by Gross et al. (50).
Diagnostic Laparoscopies
In June of 1992, 17 monkeys underwent
diagnostic laparoscopy in the facilities of
the Harlow Primate Center. Surgeries were
carried out in random order and in a
blinded fashion, without knowledge ofthe
group assignment ofeach animal. Surgeries
were performed under general anesthesia; a
10-mm diagnostic laparoscope was used to
inspect the pelvic organs, the anterior peri-
toneum, the visible bowel surfaces, the
liver edge, and the diaphragm. Clinical
findings were recorded and documented by
photography at the time of surgery. No
postoperative complications occurred in
any ofthe animals; the absence ofinfection
was confirmed by normal complete blood
cell counts and blood cultures. The pres-
ence and severity of endometriosis was
determined according to human criteria
using the revised American Fertility Society
(rAFS) classification system (51). This
system ofclassification standardizes disease
severity according to the number, size, and
location ofendometriotic implants and the
presence ofadhesions (Table 1). The stage
ofendometriosis is determined by the total
number of points assigned to endometri-
otic lesions and adhesions. Disease was
documented at the time of laparoscopy
(n= 17) or from autopsy notes (n=3).
StatisticalAnalysis
The relationship between the degree of
endometriosis and the exposure to dioxin
was evaluated by monotonic regression
analysis ofthe severity ofthe disease (rAFS
point score) versus the cumulative dose of
dioxin (dose x duration). The same results
were obtained by analyzing disease relative
to daily dioxin dose. The Cochran-Armitage
trend test was used to evaluate differences
in the frequency ofendometriosis between
control, 5 ppt, and 25 ppt animals. Further
evidence that the frequency of disease was
increased in dioxin-exposed animals rela-
tive to unexposed animals was calculated
by utilizing the retrospective data;
significant differences in the frequency of
disease between groups were determined
using the Fisher's exact test.
Table 1. The American Fertility Society Revised Classification System.a
Lesion< 1 cm, Lesion=1-3 cm, Lesion>3 cm,
Site Endometriosis points points points
Peritoneum Superficial 1 2 4
Deep 2 4 6
Ovary
Right Superficial 1 2 4
Deep 4 16 20
Left Superficial 1 2 4
Deep 4 16 20
Posterior culdesac Partial obliteration
obliteration 4 points
Complete obliteration
40 points
Site<1/3 Site=1/3-2/3 Site>2/3
Site Adhesion type enclosed, points enclosed, points enclosed, points
Ovary
Right Filmy 1 2 4
Dense 4 8 16
Left Filmy 1 2 4
Dense 4 8 16
Tube
Right Filmy 1 2 4
Dense 4 8 16
Left Filmy 1 2 4
Dense 4 8 16
'Stage of endometriosis is determined by the total number of points assigned to endometriotic lesions and
adhesions. Stage (Minimal) 1-5 points; Stage II (Mild) 6-15 points; Stage IlIl (Moderate) 16-40 points; Stage IV
(Severe) >40 points.
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Results
The presence and severity ofendometriosis
in this colony of 20 rhesus monkeys are
shown in Table 2. By rAFS staging, control
animals not exposed to dioxin exhibited
either no endometriosis (4 of6 animals) or
had minimal disease present (2 of 6 ani-
mals). In contrast, disease was absent in 2
of 7 monkeys that received 5 ppt dioxin,
whereas only 1 ofthe 7 animals exposed to
25 ppt dioxin was disease free. Moderate to
severe disease was not seen in control ani-
mals but was documented in 3 of7 (43%)
animals exposed to 5 ppt toxicant. In mon-
keys exposed to 25 ppt dioxin, moderate to
severe endometriosis was present in 5 of 7
(71%) animals. Statistical analysis revealed
that the severity of endometriosis was
significantly correlated with the dose of
dioxin administered (Figure 1).
The prevalence of spontaneous endo-
metriosis among rhesus monkeys housed at
the Harlow Primate Laboratory was exam-
ined retrospectively by analysis of pathol-
ogy notes recorded at the time of routine
autopsy. This analysis included 304 normal
noncastrated females of reproductive age
(.4 years ofage) with no history ofdioxin
exposure. Of animals surveyed, 135 were
between 4 and 13 years of age, while 169
monkeys were 13 years of age or more.
Endometriosis was not seen in animals less
than 13 years old. In contrast, disease was
documented in 51 of 169 (30%) animals
.13 years ofage. The prevalence ofspon-
taneous disease in animals of 13 years of
age or greater is in agreement with that
seen for the control animals evaluated in
the present study (2 of6 controls, 33% fre-
quency). The data presented in Table 3
demonstrate that the frequency ofendome-
triosis was also increased in dioxin-exposed
animals as compared to animals with no
history ofdioxin exposure.
Discussion
The results of these studies demonstrate
that chronic exposure to the chemical toxi-
cant dioxin is directly correlated with the
Table 2. Severity of endometriosis in dioxin-treated
rhesus monkeys.a
Classification
Group None II Ill IV
Control 4 2 0 0 0
5ppt 2 2 0 2 1
25 ppt 1 0 1 1 4
'Stage of disease was determined according to the
revised American Fertility Society classification sys-
tem. Disease was evaluated at the time of diagnostic
laparoscopy(n=17) orfrom autopsy notes(n=3).
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Figure 1. The severity of endometriosis in rhesus mon-
keys versus the cumulative dose of dioxin. Monotonic
regression analysis revealed that the severity of
endometriosis (rAFS point score) was significantly cor-
related with the dose of dioxin administered. p<0.001,
5 and 25 ppt animals compared with corresponding
values for controls; p<0.01, 5 ppt animals compared
with corresponding value for controls; p<0.05, 25 ppt
animals compared with corresponding value for 5 ppt
animals.
increased presence and severity ofendome-
triosis in rhesus monkeys. As determined
by the rAFS scoring system, Stage II, III,
and IV disease was exclusively found in
animals exposed to either 5 ppt or 25 ppt
dioxin. Furthermore, the severity of dis-
ease, as reflected by the rAFS point score,
was positively correlated with the daily and
cumulative dose ofdioxin administered.
Despite intense research efforts over the
past 40 years, the pathophysiology of
endometriosis remains incompletely under-
stood. Research has been hindered because
this disease occurs exclusively in menstruat-
ing species, including humans and nonhu-
man primates. The rhesus monkey is a
suitable model because endometriosis devel-
ops spontaneously in these animals and
resembles human disease anatomically and
clinically (52-54). Disease manifestations
include intraabdominal cyst formation and
adhesions involving the ovaries, ureters,
colon, or urinary bladder. As noted in our
study, other investigators have described
that animals with endometriosis exhibit
behavior consistent with pain, including
prostration and anorexia occurring with the
Table 3. Frequency of endometriosis in dioxin-exposed
rhesus monkeys.
Groups Statistical test pValueb
All groups (n=20) Cochran-Armitage p<0.05
Controlsa(51/169) Fisher's Exact p=0.034
versus 5 ppt(5/7)
Controlsa(51/169) Fisher's Exact p=0.005
versus 25 ppt(6/7)
'Controls with disease (30.2%) were female animals
.13 years of age housed at The Harlow Primate
Centerwith no history of dioxin exposure. bAll pvalues
are one-tailed.
menses (54-57). A unique feature ofendo-
metriosis in the rhesus monkey, unlike
human disease, is the potential for disease
fatality, particularly if intestinal blockage
occurs. Unfortunately, endometriosis is
frequently unrecognized in monkeys until
late stages of disease, and euthanasia for
humane reasons may be carried out due to
severe pain (54,57). However, reports indi-
cate that rhesus disease may respond to sur-
gical techniques or hormonal therapy as
employed to treat human endometriosis
(57,58).
The prevalence of spontaneous endo-
metriosis in animals with no history of
dioxin exposure found in our work is simi-
lar to the frequency of 26% reported in a
controlled study by Fanton and Golden
(54). The absence of disease recorded at
autopsy in animals less than 13 years ofage
suggests that the prevalence of ciinically
detectable endometriosis may increase with
advancing age, as found in human and rhe-
sus studies (54,59). Moreover, disease may
not be visually apparent at autopsy in ani-
mals before 13 years ofage, possibly due to
age related changes in the appearance of
lesions as noted in humans (59). The
prevalence ofspontaneous endometriosis in
the rhesus and the association ofadvancing
age with an increased frequency of endo-
metriosis is an intriguing finding and is
under further investigation.
An association ofendometriosis in rhe-
sus monkeys following exposure to poly-
chlorobiphenyl (PCB) compounds has
been previously described (Campbell et al.,
unpublished results). Our study supports
and extends these findings, since dioxin is
used a reference compound for halo-
genated aromatic hydrocarbons, including
PCBs (34). An increased incidence of
endometriosis in the rhesus has been docu-
mented following exposure to single-energy
proton irradiation, mixed-energy proton
irradiation, and X-rays (54,60,61). The
shortest time lapsed between irradiation
exposure and the development ofendome-
triosis in these studies was 6 years (61). In
our study, endometriosis in dioxin-exposed
monkeys was first documented 7 years
following the termination of dioxin treat-
ment. Immune system defects are a com-
mon probable factor that may contribute
to the development of endometriosis in
each of these animal models. Indeed, this
notion is consistent with human studies,
suggesting that immune mechanisms may
contribute to the disease process (62,63).
Recent reports suggest that acute dioxin
exposure in rodents alters leukocyte pro-
duction of the inflammatory mediators
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TNF and IL-6, which may play a role in
dioxin toxicity (46-48,64). In addition,
previous studies in our laboratory (27) and
others (26) have shown that peritoneal
leukocyte populations from patients with
endometriosis exhibit aberrant patterns of
IL-6 and TNF secretion. Since circulating
leukocytes represent the pool for repopula-
tion of these cells within the peritoneal
cavity, additional work is in progress to
examine the ability of peripheral blood
mononuclear cells obtained from these rhe-
sus monkeys to produce TNFa and IL-6.
Preliminary data from these studies indi-
cate that endometriosis or toxicant exposure
was associated with altered cytokine pro-
duction in response to endotoxin stimula-
tion by rhesus peripheral blood leukocytes
in vitro (65). These experiments provide
evidence that suggests the possibility of a
dysregulation of cytokine production
peripherally in monkeys exposed to dioxin
or animals with endometriosis and lend
further support to the hypothesis that this
disease may be characterized with systemic
immune alterations.
The etiology of endometriosis remains
elusive, and the potential role of dioxin in
the pathogenesis of this disease is unclear.
However, the study ofcytokine production
by peritoneal and peripheral leukocytes
and endometrial cells and the effect of
these cytokines on endometrial cell growth
may provide new directions for research. In
addition, the effect ofdioxin on the growth
of uterine and ectopic endometrial cells
and cytokine-steroid interactions is not
known and awaits future investigation.
Dioxin exerts known effects on the
immune system, including stimulation of
the secretion of cytokines, which partici-
pate in the regulation ofendometrial func-
tion (10,11,46-48). In addition, this
toxicant alters tissue-specific responses to
hormones via modulation ofsteroid recep-
tor expression (44). Chronic unregulated
cytokine secretion by leukocytes and
endometrial cells in combination with hor-
monal dysregulation may have facilitated
the aberrant growth of endometrial tissue
within the peritoneum of dioxin-treated
animals. The serendipitous finding of
endometriosis in rhesus monkeys exposed
to dioxin highlights the need for collabora-
tion between clinicians and researchers
within the fields of gynecology, immunol-
ogy, neuroendocrinology, and toxicology
to gain more insight into the effects
of environmental toxicants on human
reproductive health.
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